Thymalin is a type of medication made from calf thymus tissue that is recognized for its immune enhancing qualities. Originally created in Russia and officially approved in 2010 this drug has been employed to address ailments, like illnesses, hepatitis and tuberculosis. Its ability to regulate reactions positions it as a solution for handling serious viral infections such, as COVID 19.
Khavinson, V.K., Linkova, N.S., Kvetnoy, I.M., Polyakova, V.O., Drobintseva, A.O., Kvetnaia, T.V. and Ivko, O.M., 2020. Thymalin: Activation of differentiation of human hematopoietic stem cells. Bulletin of Experimental Biology and Medicine.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Khavinson, V.K., Linkova, N.S., Kvetnoy, I.M., Polyakova, V.O., Drobintseva, A.O., Kvetnaia, T.V. and Ivko, O.M., 2020. Thymalin: Activation of differentiation of human hematopoietic stem cells. Bulletin of Experimental Biology and Medicine.
Khavinson, V.K., Linkova, N.S., Kvetnoy, I.M., Polyakova, V.O., Drobintseva, A.O., Kvetnaia, T.V. and Ivko, O.M., 2020. Thymalin: Activation of differentiation of human hematopoietic stem cells. Bulletin of Experimental Biology and Medicine.
Khavinson, V.K., Linkova, N.S., Kvetnoy, I.M., Polyakova, V.O., Drobintseva, A.O., Kvetnaia, T.V. and Ivko, O.M., 2020. Thymalin: Activation of differentiation of human hematopoietic stem cells. Bulletin of Experimental Biology and Medicine.